Your browser doesn't support javascript.
loading
Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5-HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders.
Hopkins, Seth C; Wilkinson, Scott; Corriveau, Taryn J; Nishikawa, Hiroyuki; Nakamichi, Keiko; Loebel, Antony; Koblan, Kenneth S.
Affiliation
  • Hopkins SC; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts, USA.
  • Wilkinson S; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts, USA.
  • Corriveau TJ; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts, USA.
  • Nishikawa H; Drug Research Division, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan.
  • Nakamichi K; Drug Research Division, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan.
  • Loebel A; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts, USA.
  • Koblan KS; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts, USA.
Clin Pharmacol Ther ; 110(3): 808-815, 2021 09.
Article in En | MEDLINE | ID: mdl-33961287
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Receptors, Serotonin / Mood Disorders / Dopamine D2 Receptor Antagonists / Amisulpride Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Animals / Female / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Receptors, Serotonin / Mood Disorders / Dopamine D2 Receptor Antagonists / Amisulpride Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Animals / Female / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States